EditorialKommentar
Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone
JAMA Internal Medicine · 2023
DOI: 10.1001/jamainternmed.2023.5091 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA Internal Medicine, 2023. Verfasst von Grace Y Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco. Hauptthemen laut MEDLINE: Gender Equity, Leadership. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Gender EquityLeadershipHumansClinical Trials as Topic
Autor:innen und Institutionen
- University of California, San Francisco.
- Editorial Fellow, JAMA Internal Medicine.
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Associate Editor, JAMA Internal Medicine.
- Patient-Centered Outcomes Research Institute, Washington, DC.
Zitieren
APA
Zhang, G. Y., Ganguli, I., & Wang, T. Y. (2023). Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2023.5091
Vancouver
Zhang GY, Ganguli I, Wang TY. Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone. JAMA Internal Medicine. 2023. doi:10.1001/jamainternmed.2023.5091
BibTeX
@article{Zhang2023,
author = {Zhang, Grace Y and Ganguli, Ishani and Wang, Tracy Y},
title = {Gender Equity in Clinical Trial Leadership—A Win-Win for Everyone},
journal = {JAMA Internal Medicine},
year = {2023},
doi = {10.1001/jamainternmed.2023.5091}
}
EUVIMED